Company intelligence / Profile preview

Cryosite

South Granville, New South Wales, Australia

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Cryosite is a clinical trial logistics and biological storage service provider, not a drug developer. In FY24, the company achieved NPAT of AU$1.8m (+31% YoY), EBITDA of AU$2.8m (+28% YoY), and revenue of AU$12.6m (+6% YoY).

Modalities: Cell therapyGene therapyStem cell therapy (storage and logistics support)
Industry: Contract Research Organization

Partnerships

Serves 11 of the top 15 pharmaceutical companiesindustry-leading global Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs)universitieshospitalsresearch companies

Beyond the preview

Go deeper on Cryosite.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cryosite.

Explore the full profile